STEVEN_WEBSTER_(PHARMACIE - Accounts

Company Registration No. SC601964 (Scotland)
STEVEN WEBSTER (PHARMACIES) LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 JUNE 2021
PAGES FOR FILING WITH REGISTRAR
STEVEN WEBSTER (PHARMACIES) LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 9
STEVEN WEBSTER (PHARMACIES) LIMITED
BALANCE SHEET
AS AT 30 JUNE 2021
30 June 2021
- 1 -
2021
2020
Notes
£
£
£
£
Fixed assets
Intangible assets
4
2,444,144
2,562,792
Tangible assets
5
84,818
50,008
2,528,962
2,612,800
Current assets
Stocks
101,205
155,450
Debtors
6
2,125,935
1,925,551
Cash at bank and in hand
900,330
936,549
3,127,470
3,017,550
Creditors: amounts falling due within one year
7
(496,790)
(699,177)
Net current assets
2,630,680
2,318,373
Net assets
5,159,642
4,931,173
Capital and reserves
Called up share capital
8
51
51
Share premium account
9,999
9,999
Other reserves
9
3,529,452
3,529,452
Profit and loss reserves
1,620,140
1,391,671
Total equity
5,159,642
4,931,173

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial period ended 30 June 2021 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

STEVEN WEBSTER (PHARMACIES) LIMITED
BALANCE SHEET (CONTINUED)
AS AT 30 JUNE 2021
30 June 2021
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 21 February 2022 and are signed on its behalf by:
Stephen Webster
Steven F Webster
Director
Director
Company Registration No. SC601964
STEVEN WEBSTER (PHARMACIES) LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 JUNE 2021
- 3 -
1
Accounting policies
Company information

Steven Webster (Pharmacies) Limited is a private company limited by shares incorporated in Scotland. The registered office is 7 Queen Street, Peterhead, AB42 1TN.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Reporting period

The company has changed the accounting reference date to 30 June in order to align with their parent company.

1.4
Turnover

Turnover represents amounts receivable from the sale of products from a dispensing chemist, net of VAT.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

1.5
Intangible fixed assets - goodwill

Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 20 years.

1.6
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Leasehold improvements
10% straight line
Plant and equipment
33% straight line
Fixtures and fittings
20% straight line
Motor vehicles
25% straight line
STEVEN WEBSTER (PHARMACIES) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 JUNE 2021
1
Accounting policies
(Continued)
- 4 -

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.7
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).

1.8
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.9
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand and deposits held at call with banks.

1.10
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are measured at transaction price including transaction costs. Investments in non-puttable ordinary shares are measured at cost less impairment. Basic financial assets are assessed for indicators of impairment at each financial reporting period date with any resulting impairment recognised through profit or loss.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

STEVEN WEBSTER (PHARMACIES) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 JUNE 2021
1
Accounting policies
(Continued)
- 5 -
Basic financial liabilities

Basic financial liabilities, including creditors, are recognised at transaction price. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less.

Derecognition of financial liabilities

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

1.11
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.12
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

1.13
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

1.14
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

STEVEN WEBSTER (PHARMACIES) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 JUNE 2021
1
Accounting policies
(Continued)
- 6 -
1.15
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

1.16
Government grants

Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.

 

Government grants are recognised in accordance with the accruals model. Government grants relating to turnover are recognised as income over the periods when the related costs are incurred. Grants relating to an asset are recognised in income systematically over the asset's expected useful life. If part of such a grant is deferred it is recognised as deferred income rather than being deducted from the asset's carrying amount.

1.17
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Exceptional item
2021
2020
£
£
Expenditure
Intercompany loan write off
-
(1,066,703)

This intercompany loan write off relates to A&L Porter Limited, a company owned and controlled by the previous owners of Steven Webster (Pharmacies) Limited This was written off as part of the current shareholders acquisition of the company.

3
Employees

The average monthly number of persons (including directors) employed by the company during the period was:

2021
2020
Number
Number
Total
20
19
STEVEN WEBSTER (PHARMACIES) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 JUNE 2021
- 7 -
4
Intangible fixed assets
Goodwill
£
Cost
At 1 September 2020 and 30 June 2021
2,847,546
Amortisation and impairment
At 1 September 2020
284,754
Amortisation charged for the period
118,648
At 30 June 2021
403,402
Carrying amount
At 30 June 2021
2,444,144
At 31 August 2020
2,562,792
5
Tangible fixed assets
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost
At 1 September 2020
52,552
12,688
65,240
Additions
40,651
3,488
44,139
At 30 June 2021
93,203
16,176
109,379
Depreciation and impairment
At 1 September 2020
10,476
4,756
15,232
Depreciation charged in the period
6,193
3,136
9,329
At 30 June 2021
16,669
7,892
24,561
Carrying amount
At 30 June 2021
76,534
8,284
84,818
At 31 August 2020
42,076
7,932
50,008
STEVEN WEBSTER (PHARMACIES) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 JUNE 2021
- 8 -
6
Debtors
2021
2020
Amounts falling due within one year:
£
£
Trade debtors
250,011
157,421
Corporation tax recoverable
-
0
9,296
Amounts owed by group undertakings
1,760,884
1,692,629
Other debtors
115,040
66,205
2,125,935
1,925,551

The amounts owed by group undertakings has no formal documentation in relation to the repayment terms and has been measured as a current asset due within one year.

7
Creditors: amounts falling due within one year
2021
2020
£
£
Other borrowings
-
0
259,336
Trade creditors
358,980
321,013
Corporation tax
117,100
94,910
Other taxation and social security
-
0
6,601
Other creditors
2,710
2,799
Accruals and deferred income
18,000
14,518
496,790
699,177
8
Called up share capital
2021
2020
2021
2020
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of 10p each
500
500
50
50
ROC only shares of 10p each
6
6
1
1
506
506
51
51
9
Other reserves

The merger reserve is recognised as the difference in fair value and deemed consideration of assets transferred into the company in a prior year as part of a group reconstruction.

STEVEN WEBSTER (PHARMACIES) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 JUNE 2021
- 9 -
10
Operating lease commitments
Lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2021
2020
£
£
147,274
166,782
11
Parent company

The parent and ultimate parent company is Steven F Webster Limited. The registered office is 7 Queen Street, Peterhead, AB42 1TN.

2021-06-302020-09-01falseCCH SoftwareCCH Accounts Production 2021.300No description of principal activityStephen WebsterSteven F WebsterDiane WebsterSuzanne WebsterStephen WebsterSC6019642020-09-012021-06-30SC6019642021-06-30SC601964core:NetGoodwill2021-06-30SC601964core:NetGoodwill2020-08-31SC6019642019-09-012020-08-31SC6019642020-08-31SC601964core:LandBuildings2021-06-30SC601964core:OtherPropertyPlantEquipment2021-06-30SC601964core:LandBuildings2020-08-31SC601964core:OtherPropertyPlantEquipment2020-08-31SC601964core:CurrentFinancialInstrumentscore:WithinOneYear2021-06-30SC601964core:CurrentFinancialInstrumentscore:WithinOneYear2020-08-31SC601964core:CurrentFinancialInstruments2021-06-30SC601964core:CurrentFinancialInstruments2020-08-31SC601964core:ShareCapital2021-06-30SC601964core:ShareCapital2020-08-31SC601964core:SharePremium2021-06-30SC601964core:SharePremium2020-08-31SC601964core:OtherMiscellaneousReserve2021-06-30SC601964core:OtherMiscellaneousReserve2020-08-31SC601964core:RetainedEarningsAccumulatedLosses2021-06-30SC601964core:RetainedEarningsAccumulatedLosses2020-08-31SC601964core:ShareCapitalOrdinaryShares2021-06-30SC601964core:ShareCapitalOrdinaryShares2020-08-31SC601964bus:CompanySecretaryDirector12020-09-012021-06-30SC601964bus:Director12020-09-012021-06-30SC601964core:Goodwill2020-09-012021-06-30SC601964core:LeaseholdImprovements2020-09-012021-06-30SC601964core:PlantMachinery2020-09-012021-06-30SC601964core:FurnitureFittings2020-09-012021-06-30SC601964core:MotorVehicles2020-09-012021-06-30SC601964core:NetGoodwill2020-08-31SC601964core:NetGoodwill2020-09-012021-06-30SC601964core:LandBuildings2020-08-31SC601964core:OtherPropertyPlantEquipment2020-08-31SC6019642020-08-31SC601964core:LandBuildings2020-09-012021-06-30SC601964core:OtherPropertyPlantEquipment2020-09-012021-06-30SC601964core:WithinOneYear2021-06-30SC601964core:WithinOneYear2020-08-31SC601964bus:PrivateLimitedCompanyLtd2020-09-012021-06-30SC601964bus:SmallCompaniesRegimeForAccounts2020-09-012021-06-30SC601964bus:FRS1022020-09-012021-06-30SC601964bus:AuditExemptWithAccountantsReport2020-09-012021-06-30SC601964bus:Director22020-09-012021-06-30SC601964bus:Director32020-09-012021-06-30SC601964bus:Director42020-09-012021-06-30SC601964bus:CompanySecretary12020-09-012021-06-30SC601964bus:FullAccounts2020-09-012021-06-30xbrli:purexbrli:sharesiso4217:GBP